Mortality in sickle cell anemia in africa: A prospective cohort study in Tanzania

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Makani, Julie ^a,b   Cox, Sharon E ^a,c   Soka, Deogratius ^a   Komba, Albert N ^a   Oruo, Julie ^a   Mwamtemi, Hadija ^a   Magesa, Pius ^a   Rwezaula, Stella ^a   Meda, Elineema ^a   Mgaya, Josephine ^a   Lowe, Brett ^b,d   Muturi, David ^d   Roberts, David J ^b,e   Williams, Thomas N ^b,d,f   Pallangyo, Kisali ^a   Kitundu, Jesse ^a   Fegan, Gregory ^c,d   Kirkham, Fenella J ^g   Marsh, Kevin ^b,d   Newton, Charles R ^a,c,d,g  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Ghana)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SICKLE CELL ANEMIA; TANZANIA; TIME OF DEATH; ADOLESCENT; AFRICA; CAUSE OF DEATH; INCIDENCE; INFANT; MIDDLE AGED; NEWBORN;

ADOLESCENT; ADULT; AFRICA; ANEMIA, SICKLE CELL; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TANZANIA; YOUNG ADULT;

EID: 79951924307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014699     Document Type: Article

References (36)

1. World Health Organisation. (2006) Management of birth defects and haemoglobin disorders: report of a joint WHO-March of Dimes Meeting. Geneva World Health Organisation.
2. Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P, (2006) Inherited Disorders of Hemoglobin. In: Jamison D, editors. Disease Control Priorities in Developing Countries 2nd ed New York Oxford University Press pp. 663-80.
3. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, et al. (1989) Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics: 84 (3): 500-8.
4. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, et al. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med: 330 (23): 1639-44.
5. Kato GJ, McGowan V, Machado RF, Little JA, Taylor Jt, et al. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood: 107 (6): 2279-85.
6. Quinn CT, Rogers ZR, Buchanan GR, (2004) Survival of children with sickle cell disease. Blood: 103 (11): 4023-7.
7. Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, et al. (2007) Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica: 92 (7): 905-12.
8. Obaro S, (2009) Pneumococcal Disease in Sickle Cell Disease in Africa: Does Absence of Evidence Imply Evidence of Absence? Arch Dis Child.
9. Wierenga KJ, Hambleton IR, Lewis NA, (2001) Survival estimates for patients with homozygous sickle-cell disease in Jamaica: A clinic-based population study. Lancet: 357 (9257): 680-3.
10. Christianson AL, Howson CP, Modell B, (2006) March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children. White Plains, New York March of Dimes Birth defects Foundation.
11. National Malaria Control Programme. (2006) National Guidelines for Malaria Diagnosis and Treatment in Tanzania In: Ministry of Health and Social Welfare, editor.
12. Cnaan A, Ryan L, (1989) Survival analysis in natural history studies of disease. Stat Med: 8 (10): 1255-68.
13. Powars DR, (1975) Natural history of sickle cell disease-the first ten years. Semin Hematol: 12 (3): 267-85.
14. Powars D, Chan LS, Schroeder WA, (1990) The variable expression of sickle cell disease is genetically determined. Semin Hematol: 27 (4): 360-76.
15. Thomas AN, Pattison C, Serjeant GR, (1982) Causes of death in sickle-cell disease in Jamaica. Br Med J (Clin Res Ed): 285 (6342): 633-5.
16. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, et al. (1995) Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood: 86 (2): 776-83.
17. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G, (1995) Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ: 311 (7020): 1600-590.
18. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, et al. (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med: 314 (25): 1593-9.
19. Vichinsky EP, (1991) Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol: 28 (3): 220-6.
20. Yanni E, Grosse SD, Yang Q, Olney RS, (2009) Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr: 154 (4): 541-5.
21. de Montalembert M, Brousse V, Zahar JR, (2008) Pneumococcal prophylaxis for children with sickle cell disease in Africa. Arch Dis Child: 93 (8): 715-6.
22. Tshilolo L, Kafando E, Sawadogo M, Cotton F, Vertongen F, et al. (2008) Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: Lessons from pilot studies. Public Health: 122 (9): 933-41.
23. Odunvbun ME, Okolo AA, Rahimy CM, (2008) Newborn screening for sickle cell disease in a Nigerian hospital. Public Health: 122 (10): 1111-6.
24. Rahimy MC, Gangbo A, Ahouignan G, Alihonou E, (2009) Newborn screening for sickle cell disease in the Republic of Benin. J Clin Pathol: 62 (1): 46-8.
25. Williams TN, Uyoga S, Macharia A, Ndila C, McAuley CF, et al. (2009) Bacteraemia in Kenyan children with sickle-cell anaemia: A retrospective cohort and case-control study. Lancet.
26. Kizito ME, Mworozi E, Ndugwa C, Serjeant GR, (2007) Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? Arch Dis Child: 92 (1): 21-3.
27. Juwah AI, Nlemadim EU, Kaine W, (2004) Types of anaemic crises in paediatric patients with sickle cell anaemia seen in Enugu, Nigeria. Arch Dis Child: 89 (6): 572-6.
28. Ikefuna AN, Emodi IJ, (2007) Hospital admission of patients with sickle cell anaemia pattern and outcome in Enugu area of Nigeria. Niger J Clin Pract: 10 (1): 24-9.
29. Wahl S, Quirolo KC, (2009) Current issues in blood transfusion for sickle cell disease. Curr Opin Pediatr: 21 (1): 15-21.
30. Tshilolo LM, Mukendi RK, Wembonyama SO, (2007) Blood transfusion rate in Congolese patients with sickle cell anemia. Indian J Pediatr: 74 (8): 735-8.
31. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, et al. (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. Jama: 289 (13): 1645-51.
32. Taylor JGt, Nolan VG, Mendelsohn L, Kato GJ, Gladwin MT, et al. (2008) Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS ONE: 3 (5): e2095.
33. Olabode JO, Shokunbi WA, (2006) Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan. West Afr J Med: 25 (4): 284-8.
34. Rwezaula S, Mgaya J, Marlowe T, Reid C, Cox SE, et al. (2010) Neonatal Screening for Haemoglobinopathies at Muhimbili National Hospital, Dar-es-Salaam, Tanzania. Dar-es-Salaam Muhimbili University of Health and Allied Sciences.
35. Analysis Information Management & Communications (AIM) Activity. (2008) Tanzania: USAID country Health Statistical Report.
36. Modell B, Darlison M, (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ: 86 (6): 480-7.